Generation of a monoclonal anti-GP70 antibody and characterization of its reactivity with various human cell lines and cells from leukemia-lymphoma patients

Yair Gazitt, Marei Sammar, Abraham J. Treves, Noga Manny, Dorit Gurfel, Aaron Polliack

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Monoclonal anti GP-70 antibodies (BI) were generated in mice and used for screening of various malignant and non-malignant cell lines. The reactivity of these monoclonal antibodies was compared with that obtained with the polyclonal anti GP-70 antibody described in earlier studies [1-3]. The results indicated complete similarity in reactivity of both of the antibodies used. Furthermore, the reactivity of BI antibodies with cell samples obtained from a variety of leukemia and lymphoma patients and with peripheral blood samples from healthy blood donors was also very similar to the pattern of specificity described in earlier reports for the polyclonal preparation. From these studies we conclude that the monoclonal antibodies can substitute the polyclonal anti GP-70 antibodies in the diagnosis and subtyping of B-type leukemias and lymphomas.

Original languageEnglish (US)
Pages (from-to)101-108
Number of pages8
JournalImmunology Letters
Volume12
Issue number2-3
DOIs
StatePublished - Mar 1986
Externally publishedYes

Keywords

  • human cell lines
  • leukemia
  • lymphoma patients
  • monoclonal anti-GP70 antibody

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Generation of a monoclonal anti-GP70 antibody and characterization of its reactivity with various human cell lines and cells from leukemia-lymphoma patients'. Together they form a unique fingerprint.

Cite this